SCHEMBL21835129

SCHEMBL21835129

COC(=O)C=Cc1cc(Br)cc(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.54
AKR1C3 P42330 1/20 0.50
EPHX2 P34913 1/20 0.48
APP P05067 2/20 0.47
TTR P02766 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
TYR P14679 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
CYP1A1 P04798 3/20 0.46
CYP1B1 Q16678 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
PTPN1 P18031 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29937522 1.00 BACE1 (0.54) BACE1AKR1C3EPHX2APPTTR
SCHEMBL16307036 1.00 BACE1 (0.54) BACE1AKR1C3EPHX2APPTTR
SCHEMBL18386213 0.88 BACE1 (0.62) BACE1EPHX2APPTTRCA12
SCHEMBL6821064 0.88 AKR1C3 (0.56) BACE1AKR1C3EPHX2APPTTR
SCHEMBL6821063 0.88 AKR1C3 (0.56) BACE1AKR1C3EPHX2APPTTR
SCHEMBL2744655 0.87 F3 (0.56) BACE1CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL2744652 0.87 F3 (0.56) BACE1CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL3017298 0.85 THRB (0.57) BACE1AKR1C3CA12CA1CA2
SCHEMBL3017301 0.85 THRB (0.57) BACE1AKR1C3CA12CA1CA2
SCHEMBL22837938 0.85 MAOB (0.52) BACE1AKR1C3TTRCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063792-A1 INDOLE MACROCYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2020-04-02 WO disclosed